PH19219A - Novel pyrimidone derivatives - Google Patents

Novel pyrimidone derivatives

Info

Publication number
PH19219A
PH19219A PH30644A PH30644A PH19219A PH 19219 A PH19219 A PH 19219A PH 30644 A PH30644 A PH 30644A PH 30644 A PH30644 A PH 30644A PH 19219 A PH19219 A PH 19219A
Authority
PH
Philippines
Prior art keywords
pyrimidone derivatives
novel pyrimidone
novel
derivatives
pyrimidone
Prior art date
Application number
PH30644A
Other languages
English (en)
Inventor
Ado Dr Kaiser
Frank Dr Keinzle
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH19219A publication Critical patent/PH19219A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • C07D239/62Barbituric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH30644A 1983-05-05 1984-05-04 Novel pyrimidone derivatives PH19219A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH244283 1983-05-05
CH139284 1984-03-20

Publications (1)

Publication Number Publication Date
PH19219A true PH19219A (en) 1986-02-12

Family

ID=25687524

Family Applications (1)

Application Number Title Priority Date Filing Date
PH30644A PH19219A (en) 1983-05-05 1984-05-04 Novel pyrimidone derivatives

Country Status (16)

Country Link
US (1) US4581172A (cs)
EP (1) EP0124893A3 (cs)
AU (1) AU2751084A (cs)
CA (1) CA1237429A (cs)
CS (1) CS243486B2 (cs)
DK (1) DK198784A (cs)
ES (1) ES8505369A1 (cs)
FI (1) FI841619A (cs)
HU (1) HUT34025A (cs)
IL (1) IL71711A (cs)
MC (1) MC1600A1 (cs)
NO (1) NO841780L (cs)
NZ (1) NZ207981A (cs)
PH (1) PH19219A (cs)
PT (1) PT78549B (cs)
ZW (1) ZW6284A1 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3472678D1 (de) * 1983-07-18 1988-08-18 Beecham Group Plc Benzazepine and benzoxazepine derivatives
GB9707251D0 (en) * 1997-04-10 1997-05-28 Smithkline Beecham Plc Novel method and compounds
ES2208310T3 (es) * 1999-03-31 2004-06-16 Vernalis Limited Derivados de pirimido(6,1-a) isoquinolin-4-ona.
US7169907B2 (en) * 2002-03-01 2007-01-30 Roche Diagnostics Operations, Inc. Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs
EP1641766A2 (en) * 2003-07-08 2006-04-05 Smithkline Beecham Corporation Novel chemical compounds
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
WO2017016960A1 (en) * 2015-07-24 2017-02-02 F. Hoffmann-La Roche Ag Process for the preparation of (6s)-6-alkyl-10-alkoxy-9-(substituted alkoxy)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid analogues
GB201613054D0 (en) 2016-07-28 2016-09-14 Verona Pharma Plc New compound and process
IL280075B2 (en) * 2018-07-13 2024-06-01 Chia Tai Tianqing Pharmaceutical Group Co Ltd A conjugated tricyclic compound as a dual PDE3/PDE4 inhibitor
AU2021207159A1 (en) * 2020-01-15 2022-08-18 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Crystal of PDE3/PDE4 dual inhibitor and use thereof
CA3167378A1 (en) * 2020-01-15 2021-07-22 Chia Tai Tianqing Pharmaceutical Group Co., Ltd Pharmaceutical composition of tricyclic pde3/pde4 dual inhibitor compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) * 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
DE2720085A1 (de) * 1977-05-05 1978-11-16 Hoechst Ag Pyrimido(6,1-a)isochinolin-2-on- derivate
FI64370C (fi) * 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) * 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
DE3135831A1 (de) * 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
ES532172A0 (es) 1985-06-01
HUT34025A (en) 1985-01-28
FI841619A (fi) 1984-11-06
IL71711A0 (en) 1984-09-30
NO841780L (no) 1984-11-06
IL71711A (en) 1987-08-31
ZW6284A1 (en) 1985-10-30
FI841619A0 (fi) 1984-04-25
DK198784D0 (da) 1984-04-17
AU2751084A (en) 1984-11-08
CA1237429A (en) 1988-05-31
NZ207981A (en) 1987-05-29
MC1600A1 (fr) 1985-05-09
US4581172A (en) 1986-04-08
PT78549B (en) 1986-09-15
ES8505369A1 (es) 1985-06-01
EP0124893A2 (de) 1984-11-14
PT78549A (en) 1984-06-01
CS325584A2 (en) 1985-08-15
DK198784A (da) 1984-11-06
CS243486B2 (en) 1986-06-12
EP0124893A3 (de) 1987-11-11

Similar Documents

Publication Publication Date Title
DE3363180D1 (en) Pyrimidine derivatives
EP0123907A3 (en) Halogenopyrimidine derivatives
ZA844476B (en) Amino-pyrimidine derivatives
EP0283563A3 (en) Novel derivatives
DE3474913D1 (en) Amino-pyrimidine derivatives
ZW6284A1 (en) Novel pyrimidone derivatives
GB2142025B (en) Pyrimidine derivatives
DE3475621D1 (en) 2-dioxacycloalkylthiopenem derivatives
DE3479730D1 (en) Fluoromethylthiooxacephalosporin derivatives
ZW4583A1 (en) Pyrimidone derivatives
EG16589A (en) 2-azacycloalkylthiopenem derivatives
GB2152508B (en) Pyrimidine derivatives
GR80749B (en) Substituted pyrimidine
ZA841166B (en) Pyrimidine derivatives
DE3460649D1 (en) Cyanotercyclohexane derivatives
AR243155A1 (es) Procedimiento para la preparacion de nuevas benzamidas n-aminoetil-sustituidas.
GB8308290D0 (en) Pyrimidinone derivatives
GB8309813D0 (en) Pyrimidinetrione derivatives
PH20351A (en) Novel acylaminophenal derivatives
AR242385A1 (es) Procedimiento para preparar 4(3h)-pirimidonas 2,5 disustituidas y sus sales farmaceuticamente aceptables
GB2115415B (en) Pyrimidine derivatives
ZA843171B (en) Novel pyrimidone derivatives
ZA842595B (en) Pyrimidine derivatives
IE830351L (en) Pyrimidone derivatives
IE832322L (en) Pyrimidone derivatives